Characterization of urinary incontinence in pre-menopausal women with breast cancer treated with tamoxifen for 5 years at the National Cancer Institute

Simple item page
dc.coverageDOI: 10.1016/j.rmclc.2019.10.008
dc.creatorCárcamo, Marcela
dc.creatorBaquedano, Héctor
dc.creatorDíaz, Daniela
dc.creatorDíaz G, Paulette
dc.date2020
dc.date.accessioned05-01-2026 18:05
dc.date.available05-01-2026 18:05
dc.description<p>Background: Breast cancer is the type of cancer diagnosed most frequently in women, and the second most common cause of death from cancer in this gender. Within the indications of treatment, they are: surgery, radiotherapy, chemotherapy and endocrine therapy. The last is based on the use of tamoxifen, whose prolonged use can produce side effects such as vaginal dryness, burning, irritation, itching, dysuria, urinary incontinence, among others. Objective: To characterize urinary incontinence in pre-menopausal women with breast cancer treated with tamoxifen for 5 years at the Instituto Nacional del Cáncer. Material and method: Descriptive cross-sectional study. We included women diagnosed with breast cancer enrolled and treated at the Instituto Nacional del Cáncer. The ICIQ -SF questionnaire was applied to the study population to characterize the presence of urinary incontinence. In addition, the proportion between women with urinary incontinence and nulliparity / women with urinary incontinence and parity was calculated. Results: 93,33% presented urinary incontinence. The average age of women with urinary incontinence was 51,21 (± 4,74) years. The ratio of women with nulliparity / with parity was 4:15. Conclusion: 99,33% of the patients presented urinary incontinence. The results delivered in this study should be considered as one element that helps to detect the magnitude of this problem in the population registered and treated in the Instituto Nacional del Cáncer.</p>eng
dc.descriptionBreast cancer is the type of cancer diagnosed most frequently in women, and the second most common cause of death from cancer in this gender. Within the indications of treatment, they are: surgery, radiotherapy, chemotherapy and endocrine therapy. The last is based on the use of tamoxifen, whose prolonged use can produce side effects such as vaginal dryness, burning, irritation, itching, dysuria, urinary incontinence, among others.spa
dc.identifierhttps://investigadores.uandes.cl/en/publications/cb534ae4-6b05-4d6d-9fdf-a16bd313e624
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.31 (2020) date: 2020-05-01 nr.3 p.352-357
dc.subjectUrinary incontinence
dc.subjectbreast neoplasms
dc.subjectsurveys and questionnaires
dc.subjecttamoxifen
dc.subjectSDG 3 - Good Health and Well-being
dc.titleCharacterization of urinary incontinence in pre-menopausal women with breast cancer treated with tamoxifen for 5 years at the National Cancer Instituteeng
dc.titleCaracterización de incontinencia urinaria en mujeres premenopáusicas con cáncer de mama en tratamiento con tamoxifeno por cinco años en el Instituto Nacional del Cáncereng
dc.titleCaracterización de incontinencia urinaria en mujeres premenopáusicas con cáncer de mama en tratamiento con tamoxifeno por cinco años en el Instituto Nacional del Cáncerspa
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
Pure-CRIS